BIOMAT Database Logo BIOMAT Database Logo

Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy. 1999

B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Department of Infectious Disease, Celal Bayar University, School of Medicine, Manisa, Turkey.

Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations

Related Publications

B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
January 1987, The Journal of urology,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Granulomatous chest disease following intravesical bacillus Calmette-Guerin immunotherapy.
January 2004, Journal of thoracic imaging,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy.
October 2006, International journal of urology : official journal of the Japanese Urological Association,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Granulomatous Prostatitis Associated with Intravesical Bacillus Calmette Guerin Therapy.
January 2024, Revista da Sociedade Brasileira de Medicina Tropical,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Sepsis and granulomatous hepatitis after bacillus Calmette-Guerin intravesical installation.
May 2004, The Journal of infection,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Intravesical bacillus Calmette-Guerin therapy and associated granulomatous renal masses.
February 1986, The Journal of urology,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration.
October 1991, The Journal of urology,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
July 1993, The American journal of gastroenterology,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Granulomatous hepatitis as a complication of intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma.
January 1995, Annals of clinical and laboratory science,
B Ozbakkaloglu, and O Tünger, and S Sürücüoglu, and M Lekili, and A R Kandiloglu
Re: Intravesical bacillus Calmette-Guerin therapy and associated granulomatous renal masses.
February 1987, The Journal of urology,
Copied contents to your clipboard!